Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Market Cap	6.35B +12.6%
Revenue (ttm)	10.07B +26.3%
Net Income	609.04M +44.4%
EPS	5.65 +43.8%
Shares Out	107.42M
PE Ratio	10.47
Forward PE	n/a
Dividend	1.40 (2.37%)
Ex-Dividend Date	Nov 20, 2025

Volume	593,105
Average Volume	341,159
Open	59.70
Previous Close	59.10
Day's Range	59.00 - 60.60
52-Week Range	45.50 - 65.80
Beta	0.08
RSI	53.90
Earnings Date	Jan 28, 2026

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 4,798
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: NAVANAPHAR

Financial Performance

In fiscal year 2025, Navana Pharmaceuticals's revenue was 8.84 billion, an increase of 28.19% compared to the previous year's 6.90 billion. Earnings were 487.81 million, an increase of 20.56%.